Search

everythinglearnresearchcommunity

for

Search:↓

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

The oral supplement with Pinus pinaster and Grape seed extract, used with sunscreen, effectively and safely improved mild-to-moderate facial melasma.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

CBD may help with skin and hair issues, but more research is needed.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Some alopecia treatments might help treat COVID-19, but more research is needed.

AI and robotics are improving treatment and monitoring of neurodegenerative disorders like Parkinson's.

Clomipramine alone does not reduce overgrooming in cats with psychogenic alopecia.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Turmeric may improve knee osteoarthritis, depression, and metabolic syndrome, but evidence is weak.